Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Income towards Parent Company (2016 - 2025)

INVO Fertility (IVF) has disclosed Income towards Parent Company for 15 consecutive years, with $12.7 million as the latest value for Q2 2025.

  • On a quarterly basis, Income towards Parent Company rose 665.76% to $12.7 million in Q2 2025 year-over-year; TTM through Sep 2025 was -$8.3 million, a 11.49% decrease, with the full-year FY2024 number at -$9.1 million, down 13.21% from a year prior.
  • Income towards Parent Company was $12.7 million for Q2 2025 at INVO Fertility, up from -$17.4 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $12.7 million in Q2 2025 to a low of -$17.4 million in Q1 2025.
  • A 5-year average of -$2.2 million and a median of -$2.3 million in 2021 define the central range for Income towards Parent Company.
  • Peak YoY movement for Income towards Parent Company: plummeted 2816.08% in 2022, then skyrocketed 665.76% in 2025.
  • INVO Fertility's Income towards Parent Company stood at $101782.0 in 2021, then tumbled by 2816.08% to -$2.8 million in 2022, then rose by 27.84% to -$2.0 million in 2023, then tumbled by 81.65% to -$3.6 million in 2024, then skyrocketed by 450.55% to $12.7 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Income towards Parent Company are $12.7 million (Q2 2025), -$17.4 million (Q1 2025), and -$3.6 million (Q4 2024).